Form 4 for PRCT PROCEPT BioRobotics Corp
Accepted 2022-04-04 00:00:00 ET · period of report 2022-03-31 · accession 0001628280-22-008264 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-04 | 2022-03-31 | PRCT | Zadno Reza | Pres, CEO, Dir | A - Grant | $29.38 | +39.3K | 95.3K | +70% | +$1.15M |
| D | 2022-04-04 | 2022-03-31 | PRCT | Zadno Reza | Pres, CEO, Dir | A - Grant | $0.00 | +79.6K | 79.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-31 | A | A | 39,312 | $29.38 | 95,337 | D | — | — | (F1) These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 15, 2023, with one-quarter of the remaining RSUs vesting annually on each of the second, third, and fourth anniversary thereof, subject to the Reporting Person continuing as a service provider through such date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-03-31 | A | A | 79,584 | $0.00 | 79,584 | D | $34.99 · — to 2032-03-30 | 79,584 Common Stock | (F2) The Stock option was granted on March 31, 2022 and vests 1/48th on the anniversary of the vesting commencement date of March 15, 2022, and monthly over a four year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date. |